Programmed Death Ligand-1 Blocker [EPC] - N0000193338

Pharmacologic Class Information

Pharmacologic Code N0000193338
Pharmacologic Name Programmed Death Ligand-1 Blocker
Pharmacologic Uses
  • programmed death ligand-1 (PD-L1) blocking antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Programmed Death Ligand-1 Blocker

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Programmed Death Ligand-1 Blocker [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0310-4500Imfinzi Non-Proprietary Name: DurvalumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4611Imfinzi Non-Proprietary Name: DurvalumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
44087-3535Bavencio Non-Proprietary Name: AvelumabInjection, Solution, ConcentrateIntravenousEmd Serono, Inc.ACTIVE